跳至主要内容
临床试验/NCT02710331
NCT02710331进行中(未招募)1 期

Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III

Yale University2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2016年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
40
试验地点
2
主要终点
Change from Baseline: Road Tracking Error

研究概览

简要总结

The overarching goal of this study is to characterize the effects of ethanol and cannabinoids on simulated driving and related cognition.

详细描述

To study the effects of ethanol clamped at BAC 0.04% (equivalent to consuming approximately 2 drinks over 1 hour) and oral Dronabinol (10 mg capsule) on driving.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 55 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females 21 to 55 years of age (extremes included).
  • Exposed to cannabis at least once.
  • Exposed to alcohol at least once.
  • Able to provide informed consent.

排除标准

  • Cannabis naïve
  • Alcohol naïve
  • Positive pregnancy screen
  • Hearing deficits
  • Sesame oil allergy

研究组 & 干预措施

Active THC and Placebo Ethanol

Experimental

干预措施: Active Dronabinol (Drug)

Active THC and Placebo Ethanol

Experimental

干预措施: Placebo (Drug)

Active THC and Active Ethanol

Experimental

干预措施: Active Dronabinol (Drug)

Active THC and Active Ethanol

Experimental

干预措施: Active Ethanol (Drug)

Placebo THC and Active Ethanol

Experimental

干预措施: Placebo (Drug)

Placebo THC and Active Ethanol

Experimental

干预措施: Active Ethanol (Drug)

Placebo THC and Placebo Ethanol

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Change from Baseline: Road Tracking Error

时间窗: baseline, +100, +210 mins after start of dronabinol administration

次要结局

  • Change from Baseline: Biphasic Alcohol Effects Scale (BAES)(baseline, +60, +90, +210, +360 mins after start of dronabinol administration)
  • Change from Baseline: Visual Analog Scale (VAS)(baseline, +60, +90, +210, +360 mins after start of dronabinol administration)
  • Change from Baseline: Cognitive Test Battery(baseline, +120 mins after start of dronabinol administration)
  • Change from Baseline: Willingness to Drive Scale(baseline, +60, +90, +210, +360 mins after start of dronabinol administration)
  • Change from Baseline: Number of Joints Scale(baseline, +60, +90, +210, +360 mins after start of dronabinol administration)
  • Change from Baseline: Number of Drinks Scale(baseline, +60, +90, +210, +360 mins after start of dronabinol administration)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Deepak C. D'Souza

Professor of Psychiatry

Yale University

研究点 (2)

Loading locations...

相似试验